Browse 2,517 respiratory clinical trials enrolling across the United States and Canada. 332 people applied to respiratory studies last month. Search by city or state to find one near you.
Filter
1
Filter results
Results: 2,517
New
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
for
Alpha 1 Antitrypsin Deficiency
Location: Charleston SC, Phoenix AZ
Sponsor: Grifols Therapeutics LLC
Sex: All
Age: 18 - 70+
Code: NCT07555483
Phase 3, Recruiting
New
A Study to Assess Intravenous ABBV-1480 Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First Line Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer in Adult Participants
for
Non-Small Cell Lung Cancer
Location: Fort Wayne IN
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07756645
Phase 3, Recruiting
New
Comparative Effectiveness of Available Treatments for Sinus and Ear Infections in Children (Acute Sinusitis)
for
ACUTE SINUSITIS, Sinusitis
Location: Pittsburgh PA
Sponsor: Nader Shaikh
Sex: All
Age: 2 - 12
Code: NCT07732699
Phase 4, Recruiting
New
Multi-site Trial of a Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer
for
Advanced Lung Cancer, Dyspnea
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT06791057
Recruiting
New
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With Advanced Solid Tumors
Location: Huntersville NC, Grand Rapids MI, Irving TX
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07807956
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
New
This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is Better Than Usual Care Alone for Adult Participants After a Severe Chronic Obstructive Pulmonary Disease (COPD) Flare-Up Requiring Hospitalization
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Mullica Hill NJ
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 40+
Code: NCT07587658
Phase 4, Recruiting
New
An Educational Intervention (Lung Toolkit) for Improving Knowledge About Lung Cancer and Screening Among American Indian and Alaskan Native Cigarette Smokers, Lung PATHS Trial
for
Lung Carcinoma
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center
Sex: All
Age: 50 - 70+
Code: NCT07615764
Recruiting
New
Mindfulness Intervention to Reduce Patient Reported Symptoms in Patients With Chronic Graft-Versus-Host Disease
for
Chronic Graft Versus Host Disease,
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT07733141
Recruiting
New
Central Apnea in Heart Failure: Physiological Mechanisms to Inform Treatment
for
Sleep Disordered Breathing, Able Bodied
Location: Detroit MI
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT07210606
Phase 4, Recruiting
New
A Study to Test Obrixtamig in Combination With Pumitamig in People With Advanced Small Cell Lung Cancer (Dareon®-Rosetta35)
for
Extensive-stage Small Cell Lung Carcinoma,
Location: East Brunswick NJ
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07843940
Phase 1, Phase 2, Recruiting
New
Lung Cancer Detection in Never Smokers Using Urine Volatile Organic Compound (VOCs)
for
Lung Cancer
Location: Philadelphia PA
Sponsor: Thomas Jefferson University
Sex: All
Age: 18+
Code: NCT07871656
Recruiting
New
PMOS in OSA Pilot Study
for
PCOS, PCOS (Polycystic Ovary Syndrome), OSA,
Location: Chicago IL
Sponsor: University of Chicago
Sex: Female
Age: 18 - 40
Code: NCT07871149
Recruiting
New
Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Manchester NH, Concord NH, Saint Johnsbury VT,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT07393555
Phase 2, Recruiting
New
A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD)
for
Fibrosing Interstitial Lung Disease
Location: Boston MA, Minneapolis MN, Aurora CO
Sponsor: Boehringer Ingelheim
Sex: All
Age: 2 - 17
Code: NCT07366034
Phase 3, Recruiting
New
Measuring Nasal Airway Changes After VivAer Treatment Using AI Analysis
for
Nasal Airway Obstruction
Location: Newark DE
Sponsor: Aerin Medical
Sex: All
Age: 22 - 70+
Code: NCT07574918
Recruiting
New
A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors.